O2matic ApS is a Danish APS based in Herlev, operating in the Manufacture of medical and dental instruments and supplies sector. Incorporated in 2017, the company has 14 employees and reported a gross profit of -DKK 928.9k in its latest annual filing.
| Gross profit | -0.9M DKK | -162% |
| EBITDA | -9.5M DKK | -56% |
| Net profit | -10.5M DKK | -27% |
| Total assets | 32.2M DKK | +25% |
| Equity | 23.8M DKK | +648% |
| Employees | 14 | — |
In its most recent annual report (2025), O2matic ApS reported a gross profit of -DKK 928.9k, a decrease of 162% on the year before. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of DKK 10.5m.
At the end of 2025, equity financed 73.9% of the balance sheet, and current assets covered short-term debt 1.7 times.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross profit | -929 | 1,510 | -843 | 1,457 | 1,045 |
| Staff expenses | -8,610 | -7,635 | -5,947 | -5,067 | -1,375 |
| EBITDA | -9,539 | -6,125 | -8,813 | -3,610 | -330 |
| Depreciation & amort. | -1,542 | -1,391 | -738 | -311 | -311 |
| EBIT | -11,081 | -7,516 | -9,551 | -3,921 | -641 |
| Net financials | 577 | -1,461 | -680 | -171 | -15 |
| Profit before tax | -10,504 | -8,977 | -10,232 | -4,092 | -656 |
| Tax | -0 | -708 | -2,136 | -1,086 | -408 |
| Net profit | -10,504 | -8,269 | -8,096 | -3,006 | -248 |
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 32,163 | 25,812 | 24,264 | 28,603 | 22,489 |
| Equity | 23,754 | -4,334 | 3,935 | 12,028 | 7,067 |
| Long-term debt | 410 | 22,879 | 12,064 | 6,233 | 0 |
| Short-term debt | 7,999 | 7,267 | 8,266 | 8,100 | 12,728 |
| Total debt | 8,409 | 30,146 | 20,329 | 14,332 | 12,728 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Net profit as a percentage of total assets — the return generated on the capital employed.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ML Chief Executive Officer | Chief Executive Officer | 2025 |
FS Chief Executive Officer | Chief Executive Officer | 2025 – 2025 |
OI Chief Executive Officer | Chief Executive Officer | 2017 – 2024 |
AL Chief Executive Officer | Chief Executive Officer | 2024 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
FS Deputy Chairman | Deputy Chairman | 2025 |
GG Board of Directors | Board of Directors | 2026 |
EF Board of Directors | Board of Directors | 2024 |
JK Chairman | Chairman | 2024 |
LS Board of Directors | Board of Directors | 2017 – 2024 |
CM Board of Directors | Board of Directors | 2024 – 2026 |
TW Board of Directors | Board of Directors | 2019 – 2023 |
JD Board of Directors | Board of Directors | 2017 – 2023 |
OK Board of Directors | Board of Directors | 2023 – 2024 |
ML Deputy Chairman | Deputy Chairman | 2025 – 2025 |
| Shareholder | Type | Ownership | Votes | Registered |
|---|---|---|---|---|
| Company | 33.33–49.99% | 33.33–49.99% | 2026 | |
| Company | 20–24.99% | 20–24.99% | 2026 | |
| Company | 15–19.99% | 15–19.99% | 2026 | |
| Company | 5–9.99% | 5–9.99% | 2025 | |
| Company | 5–9.99% | 5–9.99% | 2018 | |
| Individual | 25–33.32% | 25–33.32% | 2022 | |
| Company | 5–9.99% | 5% | 2025 | |
| Company | 5–9.99% | 5% | 2025 | |
| Company | 50–66.65% | 50–66.65% | 2017 |
| Person | Role here | Other companies |
|---|---|---|
| Claudia Maria Colciago | Board of Directors | 7 companiesMany roles |
| Ole Kring | Board of Directors | 6 companiesMany roles |
| Lars Seier Pedersen | Board of Directors | 5 companies |
| Farzad Saber | Chief Executive Officer | 3 companies |
| Okan Ilker Görgen | Chief Executive Officer | 3 companies |
| Jacob Kildegaard Larsen | Chairman | 3 companies |
| Torben Winther Kristensen | Board of Directors | 2 companies |
| Jens Dahlgaard Hove | Board of Directors | 2 companies |
| Ejvind Frausing Hansen | Board of Directors | 2 companies |
| Arnt Lund | Chief Executive Officer | 1 company |
| Marie-Louise Little | Chief Executive Officer | 1 company |